What: Experts and affected women are exploring a condition sometimes dubbed ‘post‐birth control syndrome,’ noting that long‐term hormonal changes may mask underlying issues.
Key line: “More research is needed to understand these post‐cessation effects,” according to reproductive specialists.
Source: Cosmopolitan UK.
Chiquita Brooks-LaSure warns that cuts by Elon Musk’s DOGE team could jeopardize health insurance coverage for many American women, affecting both Medicaid and Medicare.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
Profiles reveal that women in states with strict abortion bans are avoiding pregnancy for fear of inadequate health care.
The abrupt cancellation of NIH meetings may hinder critical medical research.
Employers are responding to rising fertility costs by increasing access to preconception care, according to new research.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
A study from the University of Washington finds significant racial and socioeconomic disparities in accessing same-day diagnostic services after an abnormal mammogram.
Vox examines strategies that might let Trump maintain a moderate image on abortion while enforcing restrictions.
Women voice frustrations over intrusive social media ads during perimenopause.
The Trump IVF Executive Order does not make IVF free but instead asks for policy recommendations to lower costs, marking an initial step.
Michigan law now allows pharmacists to prescribe birth control amid a shortage of OB/GYNs.
A new survey reveals nearly one in four women under 50 consider health influencers as reliable as healthcare providers.
An obituary celebrating Carol Downer’s lifelong advocacy for abortion rights.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
A New York physician faces indictment in Louisiana for prescribing abortion pills.
New York introduces a shield law to protect doctors who prescribe abortion medications.
A California study found that over 60% of pregnancy-related hemorrhage deaths were preventable due to delays in response and inadequate management.
Research shows the causes of maternal mortality differ widely from state to state.
The Cut’s Beauty Editor examines Botox resistance—a rare phenomenon where antibodies may reduce the effectiveness of neuromodulators like Botox.